Nestle raises stake in food allergy drug developer Aimmune

The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics, as the drug developer prepares to submit a marketing application for its peanut allergy treatment by the end of the year. (Source: Reuters: Health)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2T7WwMA